To identify small molecule compounds capable of inhibiting cancer cell invasion, a novel three-dimensional high-throughput invasion assay was used to screen the National Cancer Institutes Developmental Therapeutics Program compound library (Diversity Set II) against aggressive, androgen-independent PC3 human prostate cancer cells

To identify small molecule compounds capable of inhibiting cancer cell invasion, a novel three-dimensional high-throughput invasion assay was used to screen the National Cancer Institutes […]

Continue reading